News - NLSDays - NLSDays

Latest news in cooperation with Nordic Life Science

Lundbeck and Rigshospitalet announce brain disease partnership

15 January 2021 | 7:40 am

Lundbeck enters a partnership with the Department of Neurosurgery at Rigshospitalet, which will provide new insights into how molecules enter the brain. The partnership gives researchers an opportunity to study fluids surrounding the brain to learn which compounds enter the brain and how they are distributed. The findings will be published as basic research, but […]

Follicum receives European patent

14 January 2021 | 5:52 am

Follicum has announced that the European Patent Office (EPO) has approved a patent which refers to the company’s novel peptides that are being developed to treat diabetes. The approval follows the previous provisional approval by the EPO announced on March 20, 2020. The approval provides protection for the company’s peptides and their use to treat […]

She is the new CEO of the Center for Translational Research Sweden

14 January 2021 | 5:15 am

The Center for Translational Research Sweden (CTR) has announced that the Board has appointed Karin Meyer as their new Chief Executive Officer. Karin Meyer succeeds Mats Lindquist who has been CEO since the foundation of CTR in 2016. She will begin her new position on May 1st 2021. Karin Meyer has long experience of having […]

Nanobodies show promising effects against COVID-19 infection

13 January 2021 | 7:39 am

Researchers have developed new small antibodies, nanobodies, which prevent the SARS-CoV-2 coronavirus from entering human cells. In a new study, published in Science, researchers from Karolinska Institutet in collaboration with researchers at the University of Bonn in Germany and the Scripps Research Institute in California, show that a combined nanobody had a particularly good effect – even […]

New in vitro study results about Pfizer/BioNTech’s COVID-19 vaccine

12 January 2021 | 8:19 am

Pfizer and BioNTech have announced results from an in vitro study that shows the antibodies from people who have received their vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains. The results were published on the preprint server bioRxiv. Variants of SARS-CoV-2 Rapidly spreading variants of SARS-CoV-2 […]

BioInvent streamlines agreement on its BI-1206 antibody

12 January 2021 | 8:03 am

BioInvent International has restructured a clinical development agreement with Cancer Research UK (CRUK) for its anti-FcγRIIB antibody, BI-1206. In exchange for a one-time payment, the revised deal simplifies and reduces BioInvent’s obligations to CRUK, which provides BioInvent with more flexibility to carry out development and partnering activities with BI-1206. It follows BioInvent’s exclusive licensing agreement […]

Ultimovacs announces Phase II collaboration study in ovarian cancer

12 January 2021 | 7:58 am

Ultimovacs will participate in the Phase II DOVACC collaboration study with the Nordic Society of Gynaecological Oncology – Clinical Trial Unit (NSGO-CTU), the European Network of Gynaecological Oncological Trial Groups (ENGOT) and AstraZeneca. The collaborators will conduct a randomized Phase II clinical trial to evaluate Ultimovacs’ universal cancer vaccine, UV1, in combination with AstraZeneca’s durvalumab […]

AstraZeneca’s Farxiga granted Priority Review in the US

12 January 2021 | 4:19 am

AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D). The Food and Drug Administration (FDA) grants Priority Review to regulatory submissions for medicines that offer significant advances over available options by demonstrating safety or efficacy improvements, […]

Alligator Bioscience recruits new Chief Medical Officer

11 January 2021 | 12:49 pm

Alligator Bioscience has appointed Dr Christina Reimer as Chief Medical Officer. Dr Reimer will replace Dr Charlotte Russel and be overall medically responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies. She will report to Head of R&D, EVP Malin Carlsson, and be part of […]

Biomedicum nominated for an EU mies award 2022

11 January 2021 | 4:23 am

Biomedicum in Stockholm, designed by C.F. Møller Architects for Akademiska Hus and Karolinska Institutet, is a European Union Prize for Contemporary Architecture – Mies van der Rohe Award 2022 nominee. The new laboratory building Biomedicum is a powerhouse for research at the Karolinska Institutet in Stockholm, one of the world’s leading medical universities. Biomedicum was […]

Latest news in cooperation with Nordic Life Science

Lundbeck and Rigshospitalet announce brain disease partnership

Follicum receives European patent

She is the new CEO of the Center for Translational Research Sweden

Nanobodies show promising effects against COVID-19 infection

New in vitro study results about Pfizer/BioNTech’s COVID-19 vaccine

BioInvent streamlines agreement on its BI-1206 antibody

Ultimovacs announces Phase II collaboration study in ovarian cancer

AstraZeneca’s Farxiga granted Priority Review in the US

Alligator Bioscience recruits new Chief Medical Officer

Biomedicum nominated for an EU mies award 2022

Join the conference!

Join the conference!

© 2021 SwedenBIO. All Rights Reserved
Legal Notices

Latest news in cooperation with Nordic Life Science

Join the conference!

© 2021 SwedenBIO. All Rights ReservedLegal Notices

© 2021 SwedenBIO. All Rights Reserved
Legal Notices